Correlation Between Johnson Johnson and Antisense Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Johnson Johnson and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Antisense Therapeutics.

Diversification Opportunities for Johnson Johnson and Antisense Therapeutics

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Johnson and Antisense is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Antisense Therapeutics go up and down completely randomly.

Pair Corralation between Johnson Johnson and Antisense Therapeutics

Considering the 90-day investment horizon Johnson Johnson is expected to generate 0.21 times more return on investment than Antisense Therapeutics. However, Johnson Johnson is 4.8 times less risky than Antisense Therapeutics. It trades about -0.28 of its potential returns per unit of risk. Antisense Therapeutics Limited is currently generating about -0.31 per unit of risk. If you would invest  16,367  in Johnson Johnson on August 25, 2024 and sell it today you would lose (850.00) from holding Johnson Johnson or give up 5.19% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Johnson Johnson  vs.  Antisense Therapeutics Limited

 Performance 
       Timeline  
Johnson Johnson 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Johnson Johnson has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively steady basic indicators, Johnson Johnson is not utilizing all of its potentials. The latest stock price chaos, may contribute to medium-term losses for the stakeholders.
Antisense Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Antisense Therapeutics Limited are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak forward-looking indicators, Antisense Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Johnson Johnson and Antisense Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Johnson Johnson and Antisense Therapeutics

The main advantage of trading using opposite Johnson Johnson and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.
The idea behind Johnson Johnson and Antisense Therapeutics Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences